Lv63
2220 积分 2021-02-15 加入
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
8天前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
14天前
已完结
Vascular damage in systemic lupus erythematosus
18天前
已完结
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study
20天前
已关闭
Targeting HER2-positive breast cancer: advances and future directions
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Current and emerging prospects in the psoriatic treatment
4个月前
已完结
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
4个月前
已完结
Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: An analysis of current evidence
4个月前
已完结
皖公网安备34019202002308
